Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 6Neoplasms 3Lung Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion 1Pituitary Diseases 1Pituitary ACTH Hypersecretion 1Obesity 1Myasthenia Gravis 1Motor Activity 1Lymphoma 1Kidney Neoplasms 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Everolimus 3liposomal doxorubicin 2Sorafenib 2Panobinostat 2Injections 2toripalimab 1titanium silicide 1temsirolimus 1satraplatin 1pembrolizumab 1netrin-1 inhibitor NP137 1navoximod 1mogamulizumab 1ixabepilone 1fludarabine 1apatinib 1Vinorelbine 1S 1 (combination) 1Radiosurgery 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Linoleic Acids, Conjugated 1Leucovorin 1Lenalidomide 1Lapatinib 1Interferon-gamma 1Immune Checkpoint Inhibitors 1Hydroxyurea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Solid Tumors × Biomarkers × Clear all
NCT01867073 2013-06-03

A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

National University Hospital, Singapore

Unknown
20 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡